medigraphic.com
ISSN 1561-2996 (Electronic)
ISSN 0864-0289 (Print)

2022, Number 4

Next >>

Rev Cubana Hematol Inmunol Hemoter 2022; 38 (4)

Importance of the immunophenotypic diagnosis by flow cytometry of myelodysplastic syndromes

Duarte PY, Marsán SV, Triana MY

Language: Spanish
References: 10
Page: 1-5
PDF size: 232.89 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Alfonso G, Arbelbide J, Basquiera AL, Cismondi V, Crisp R, De Dios Soler M, et al. Síndromes mielodisplásicos y síndromes de superposición mielodisplasia/neoplasia mieloproliferativa. Sociedad Argentina de Hematología. Guías de diagnóstico y tratamiento; 2019[acceso 21/01/2021]:667-97. Disponible en: Disponible en: http://www.sah.org.ar/docs/2019/Sindromes_Mielodisplasicos_y_Sindromes_de_Superposicion_Mielodisplasia_Neoplasia_Mieloproliferativa.pdf 1.

  2. Dhingra G, Dass J, Arya V, Gupta N, Saraf A, Langer S, et al. Evaluation of multiparametric flow cytometry in diagnosis & prognosis of myelodysplastic syndrome in India. Indian J Med Res. 2020;152(3):254-62. DOI: https://10.4103/ijmr.IJMR_924_182.

  3. Araújo HV, Correia RP, Bento LC, Vaz ADC, Sousa FA, Alexandre AM, et al. Myelodysplastic syndrome: validation of flow cytometry multilineage score system. Einstein (Sao Paulo). 2020;18:eAO4966. DOI: https://10.31744/einstein_journal/2020AO49663.

  4. Della Porta MG, Picone C. Diagnostic Utility of Flow Cytometry in Myelodysplastic Syndromes. Mediterr J Hematol Infect Dis. 2017;9(1):e2017017. DOI: https://10.4084/MJHID.2017.0174.

  5. Cameirão Bento L, Patussi Correia R, Pitangueiras Mangueira CL, De Souza Barroso R, Agostini Rocha F, Strachman Bacal N, et al. The Use of Flow Cytometry in Myelodysplastic Syndromes: A Review. Front Oncol. 2017;7:270. DOI: https://10.3389/fonc.2017.002705.

  6. Porwit A. Is There a Role for Flow Cytometry in the Evaluation of Patients with Myelodysplastic Syndromes? Curr Hematol Malig Rep. 2015;10(3):309-17. DOI: https://10.1007/s11899-015-0272-36.

  7. Hyldig Matzen SM, Raaschou-Jensen KK, Kallenbach K. Implementation of the Ogata flow cytometric scoring system in routine diagnostics of myelodysplastic syndrome. Health Sci Rep. 2018;1(11):e90. DOI: https://10.1002/hsr2.907.

  8. Duetz C, Westers Th M, van de Loosdrecht AA. Clinical Implication of Multi-Parameter Flow Cytometry in Myelodysplastic Syndromes. Pathobiology. 2019;86(1):14-23. DOI: https://10.1159/0004907278.

  9. Duetz C, Van Gassen S, Westers ThM, van Spronsen MF, Bachas C, Saeys I and van de Loosdrecht AA. Computational flow cytometry as a diagnostic tool in suspected -myelodysplastic syndromes. Cytometry A. 2021;99(8):814-24. DOI: https://10.1002/cyto.a.243609.

  10. Magalhães SMM, Niero-Melo L, Chauffaille MLLF, Velloso EDRP, Lorand-Metze I, Buzzini R, Bernardo WM. et al Guidelines on myelodysplastic syndromes: Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular. Hematol Transfus Cell Ther. 2018;40(3):255-61. DOI:https://10.1016/j.htct.2018.05.00410.




2020     |     www.medigraphic.com